Cargando…
Cardiovascular Risk Factors and Chronic Kidney Disease—FGF23: A Key Molecule in the Cardiovascular Disease
Patients with chronic kidney disease (CKD) are at increased risk of mortality, mainly from cardiovascular disease. Moreover, abnormal mineral and bone metabolism, the so-called CKD-mineral and bone disorder (MBD), occurs from early stages of CKD. This CKD-MBD presents a strong cardiovascular risk fo...
Autores principales: | Jimbo, Rika, Shimosawa, Tatsuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3941790/ https://www.ncbi.nlm.nih.gov/pubmed/24678415 http://dx.doi.org/10.1155/2014/381082 |
Ejemplares similares
-
FGF23 in Cardiovascular Disease: Innocent Bystander or Active Mediator?
por: Stöhr, Robert, et al.
Publicado: (2018) -
Corrigendum: FGF23 in Cardiovascular Disease: Innocent Bystander or Active Mediator?
por: Stöhr, Robert, et al.
Publicado: (2018) -
FGF23 and Phosphate–Cardiovascular Toxins in CKD
por: Vogt, Isabel, et al.
Publicado: (2019) -
FGF23 in Chronic Kidney Disease: Bridging the Heart and Anemia
por: Figurek, Andreja, et al.
Publicado: (2023) -
Molecular Mechanisms of Na-Cl Cotransporter in Relation to Hypertension in Chronic Kidney Disease
por: Liang, Lijuan, et al.
Publicado: (2022)